innovagenome S.r.l. is the innovative start up entirely controlled by nico innovagroup S.r.l., dedicated to personalized genomics, bioinformatics and artificial intelligence (AI).
innovagenome S.r.l. offers innovative solutions for sequencing, analysis and digital storage of the whole genome (WGS) and of the whole exome (WES), for DNA analysis using global screening array (GSA) and virtual panels and for
genomics applied to infertility.
innovagenome S.r.l. develops and uses proprietary and highly advanced bioinformatics analysis and artificial intelligence (AI) tools for the processing and interpretation of genomic data, the preparation of complete and customized reports and the safe storage of the digital copy of the genome.
nico innovagroup S.r.l. limited liability company with a single shareholder
start-up company established pursuant to art. 4 paragraph 10 bis D.L. 24 January 2015, n. 3 registered in the special section as an innovative start-up
Pursuant to the New Guidelines of the Ministry of Health of 28/03/2013, relating to health advertising concerning medical devices, in vitro diagnostic medical devices and surgical medical devices, the user is advised that, unless otherwise indicated, the the information contained therein is intended exclusively for healthcare professionals.
The information contained in this Website and in related Websites is aimed at improving, and not replacing, the doctor-patient relationship. None of the information reported is intended to help diagnose diseases and/or to indicate possible therapies.
